Flexbumin Solution
Product Images NDC 0944-0493

Albumin (Human) - 5% solution for infusion, packaged in a single-dose container of 50 mL containing 125g of human albumin obtained from screened donors. The albumin is stabilized with the addition of 0.25 L of 0.25% (w/v) sodium caprylate and 0.02% (w/v) sodium N-acetyltryptophanate and heated for 10 hours at 60°C in the preparation process. It is useful for treating patients suffering with low albumin levels. However, it should be used with caution in patients with marked dysfusion in the circulatory system. It is recommended not to use the product if it contains any particulate matter and to administer within 4 hours after the container has been opened. It should be stored at room temperature below 25°C and should not be frozen. The package has further details, and the trademark holder is Baxalta US Inc.*

This is a product description for Albumin Human a solution for infusion that comes in a single-dose container. The text includes important details, such as the concentration of the solution and storage recommendations. The product is produced by a company called B Corporated, and there are some registered trademarks mentioned (FLEGUMIN and TAGORS).*

Pierionid is a solution for infusion provided in a single-dose container. Each 100 ml of the solution contains 25 g of albumin from venous plasma in buffered diluent, which is equivalent to 500 ml of normal human plasma. The solution has been stabilized with sodium caprylate and N-acetyltryptophan and has been heated for 10 hours at 60°C. It has a sodium content of 145 ± 15 mEq/L and contains no preservatives. The patient should discuss risks and benefits with their physician before use. The recommended storage is at room temperature not exceeding 25°C with protection from freezing. Check for leaks before use, do not use if turbid, and do not begin administration more than 4 hours after the container has been entered. Pierionid is a registered trademark of Baxalta Incorporated. Takeda Pharmaceutical Company Limited owns the registered trademarks of Takeda® and Takeda Logo®.*

Solution for infusion in single dose containers of 6x100mL. Recommended storage is at room temperature, not exceeding 25°C to prevent freezing. The product is registered under the trademark FLEXGUMIN® by Saxata Incorporated. The text also mentions TAXEDA and TAKEDA 09 as registered trademarks of Takeda PharmaceutIcl Company.*